• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 100 of 100
Roche Holding AG's Headquarters As Drugmaker Acquires InterMune Inc. For $8.3 Billion
Roche shares tumble after Alzheimer’s drug failure
By ReutersDecember 19, 2014
Inside Rite Aid Ahead of Earnings Reports
Features
Rite Aid’s healthcare investments are paying off
By Laura LorenzettiDecember 18, 2014
Drug-resistant infections could cost the global economy $100 trillion by 2050
Features
Drug-resistant infections could cost the global economy $100 trillion by 2050
By Laura LorenzettiDecember 12, 2014
Greg Wasson of Walgreen's in Chicago for Fotune 6-27-13
Retail
Walgreen CEO to leave after Alliance Boots deal in reversal of plan
By Phil WahbaDecember 10, 2014
Valeant Offers to Buy Allergan With Pershing's Support
Finance
Valeant puts dealmaking on hold to focus on the bottom line
By Laura LorenzettiDecember 9, 2014
Merck takes aim at superbugs with $9.5 billion deal for Cubist
Finance
Merck takes aim at superbugs with $9.5 billion deal for Cubist
By ReutersDecember 8, 2014
BRITAIN-PHARMACEUTICAL-GSK
GSK cuts U.S. research and sales jobs as market gets tougher
By ReutersDecember 4, 2014
Images Of Over-The-Counter Medicines And Dietary Supplements By Japanese Drugmakers
Features
Japan’s Otsuka to buy U.S. drug maker Avanir for $3.5 billion
By Laura LorenzettiDecember 2, 2014
Las Vegas Hit By Economic Downturn
Finance
Wynn Resorts under investigation for potential money laundering
By Tom Huddleston Jr.November 21, 2014
Valeant Offers to Buy Allergan With Pershing's Support
After losing out over Allergan, Valeant announces $2 billion buyback
By Geoffrey SmithNovember 21, 2014
Your pharmacist called. You owe $1.3 trillion.
Features
Your pharmacist called. You owe $1.3 trillion.
By Erika FryNovember 20, 2014
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
Pfizer to pay up to $2 billion for cancer alliance with Germany’s Merck
By Geoffrey SmithNovember 17, 2014
Laid-Off Workers Get Employment Tips And Free Botox Treatments
Finance
Allergan in talks with another bidder as it looks to thwart Valeant
By Laura LorenzettiNovember 6, 2014
CVS Caremark Reports Quarterly Profit Increase Of 25 Percent
Retail
CVS Health’s tobacco ban hits retail sales after one month
By Laura LorenzettiNovember 4, 2014
Chris Viehbacher, Chief Executive Officer Of Sanofi Interview
Leadership
Sanofi’s CEO ouster: A snowball of bad judgment calls
By Eleanor BloxhamOctober 30, 2014
1...
  • 96
  • 97
  • 98
  • 99
  • 100
100
Most Popular
North America
Pentagon orders bases to plan for 90 days without the grid as Britain urges families to stockpile food and waterplaceholder alt text
By Bilin LinOctober 26, 2026
Europe
‘It’s only when you see 49-ton trucks in China running on batteries that you realize how serious electrification is’: Octopus Energy CEO Greg Jackson on Europe’s incumbency problemplaceholder alt text
By Kamal AhmedOctober 30, 2026
Real Estate
The Pentagon and Britain are bracing for the power to go out. The ultrawealthy got there first, with backup generators, escape homes, and stockpilesplaceholder alt text
By Sydney LakeOctober 30, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.